Not provided
Not provided
Not provided
Not provided
Not provided
negative information
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| First Affiliated Hospital of Wenzhou Medical University | OTHER |
| Second Affiliated Hospital of Wenzhou Medical University | OTHER |
| Zhejiang University | OTHER |
Not provided
Not provided
Not provided
Stroke has the characteristics of high morbidity, disability and fatality rate, which brings heavy spiritual and economic burdens to the family, society and the country. In my country, 33%-50% of ischemic strokes are attributed to intracranial atherosclerosis.
Studies have shown that oxidative stress, increased blood viscosity, and damage to vascular endothelial cells are important mechanisms for the development of cerebral infarction. Salvia miltiorrhiza is a commonly used traditional Chinese medicine in traditional medicine in my country. Salvia miltiorrhiza polyphenolic acid is the effective ingredient of salvia miltiorrhiza. It is the water-soluble active part of salvia miltiorrhiza. It can resist oxidation, anticoagulation, antiplatelet, cell protection, and expand blood vessels, thereby achieving protection Cardiovascular system.
The purpose of this study was to evaluate the effects and adverse effects of salvianolic acid on acute ischemic stroke onset within 72 hours, and to evaluate the improvement of patients' ischemic area perfusion and clinical function scores.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| salvianolic acid group | Active Comparator | salvianolic acid group 100mg+0.9%NaCl 250ml, injection, 14 days |
|
| 0.9% NaCl | Placebo Comparator | 0.9%NaCl 250ml, injection, 14 days |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Salvianolic Acid | Drug | salvianolic acid, injection, 100mg+0.9%NaCl 250ml, qd, 14 days |
|
| Measure | Description | Time Frame |
|---|---|---|
| MRS score | MRS score ≤2 | 90 days |
| Measure | Description | Time Frame |
|---|---|---|
| Cerebral blood flow volume (CBV) | Cerebral blood flow volume | 90 days |
| Cerebral blood flow (CBF) | Cerebral blood flow | 90 days |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Dai Haibin | Hangzhou | Zhejiang | 310009 | China |
Not provided
| ID | Term |
|---|---|
| D020521 | Stroke |
| D000083242 | Ischemic Stroke |
| ID | Term |
|---|---|
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| C568740 | salvianolic acid |
| D000077330 | Saline Solution |
| ID | Term |
|---|---|
| D000077324 | Crystalloid Solutions |
| D007552 | Isotonic Solutions |
| D012996 | Solutions |
| D004364 | Pharmaceutical Preparations |
Not provided
Not provided
| Ningbo No. 1 Hospital |
| OTHER |
| Zhejiang Hospital | OTHER |
| Zhejiang Provincial Tongde Hospital | OTHER |
| The First Affiliated Hospital of Zhejiang Chinese Medical University | OTHER |
| Xiaoshan People's Hospital | OTHER |
| Red Cross Hospital, Hangzhou, China | OTHER |
Not provided
Not provided
Not provided
Not provided
| 0.9% NaCl | Drug | 0.9% NaCl |
|
| NIHSS score | NIHSS score | 90 days |
| Adverse drug reactions (ADR) | Adverse drug reactions | 90 days |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |